114 related articles for article (PubMed ID: 2403366)
21. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
Natesh R; Schwager SL; Sturrock ED; Acharya KR
Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
[TBL] [Abstract][Full Text] [Related]
22. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines.
Ciabatti R; Padova G; Bellasio E; Tarzia G; Depaoli A; Battaglia F; Cellentani M; Barone D; Baldoli E
J Med Chem; 1986 Mar; 29(3):411-7. PubMed ID: 3005576
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of new angiotensin converting enzyme inhibitors during continuous angiotensin I infusion on conscious dogs.
Hütter JF; Dehn A; Schmidt W
Arzneimittelforschung; 1988 Jul; 38(7):896-901. PubMed ID: 2849951
[TBL] [Abstract][Full Text] [Related]
25. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Loots MJ; Perri MG; Petrillo EW; Powell JR
J Med Chem; 1988 Jan; 31(1):204-12. PubMed ID: 3336020
[TBL] [Abstract][Full Text] [Related]
26. [Dipeptidase activity in the small intestine of patients with chronic nonspecific enteritis].
Nikolov N; Nedkov-Bratanova N; Ivano E; Kr"steva A; Lozanova L
Vutr Boles; 1975; 14(1):11-6. PubMed ID: 1189389
[TBL] [Abstract][Full Text] [Related]
27. Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
Raddatz P; Minck KO; Rippmann F; Schmitges CJ
J Med Chem; 1994 Feb; 37(4):486-97. PubMed ID: 8120867
[TBL] [Abstract][Full Text] [Related]
28. Transpeptidation reactions of a specific substrate catalyzed by the Streptomyces R61 DD-peptidase: the structural basis of acyl acceptor specificity.
Kumar I; Pratt RF
Biochemistry; 2005 Aug; 44(30):9961-70. PubMed ID: 16042373
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
[TBL] [Abstract][Full Text] [Related]
30. Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.
Everett DW; Singhvi SM; DeForrest JM; Morrison RA; Weinstein SH; Migdalof BH
Drug Des Deliv; 1987 Sep; 2(1):23-34. PubMed ID: 3509342
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
Krapcho J; Turk C; Cushman DW; Powell JR; DeForrest JM; Spitzmiller ER; Karanewsky DS; Duggan M; Rovnyak G; Schwartz J
J Med Chem; 1988 Jun; 31(6):1148-60. PubMed ID: 2836590
[TBL] [Abstract][Full Text] [Related]
32. Cleavage of the peptide bond of beta-alanyl-L-histidine (carnosine) induced by a Co(III)-amine complexes: reaction, structure and mechanism.
Saha MK; Mukhopadhyay U; Bernal I
Dalton Trans; 2004 May; (9):1466-73. PubMed ID: 15252643
[TBL] [Abstract][Full Text] [Related]
33. A DmpA-homologous protein from Pseudomonas sp. is a dipeptidase specific for beta-alanyl dipeptides.
Komeda H; Asano Y
FEBS J; 2005 Jun; 272(12):3075-84. PubMed ID: 15955066
[TBL] [Abstract][Full Text] [Related]
34. Irreversible inhibition of bovine lung angiotensin I-converting enzyme with p-[N,N-bis(chloroethyl)amino]phenylbutyric acid (chlorambucil) and chlorambucyl L-proline and with evidence that an active site carboxyl group is labeled.
Harris RB; Wilson IB
J Biol Chem; 1982 Jan; 257(2):811-5. PubMed ID: 6274865
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of 4-hydroxy-4-(4-methoxyphenyl)-substituted proline and pyrrolidin-2-ylacetic acid derivatives as GABA uptake inhibitors.
Zhao X; Pabel J; Höfner GC; Wanner KT
Bioorg Med Chem; 2013 Jan; 21(2):470-84. PubMed ID: 23245753
[TBL] [Abstract][Full Text] [Related]
36. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
Ondetti MA; Rubin B; Cushman DW
Science; 1977 Apr; 196(4288):441-4. PubMed ID: 191908
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activity of an amino analogue of a tripeptide inhibitor of angiotensin-converting enzyme.
Almquist RG; Christie PH; Chao WR; Johnson HL
J Pharm Sci; 1983 Jan; 72(1):63-7. PubMed ID: 6298401
[TBL] [Abstract][Full Text] [Related]
38. Effects of L-proline and some of its analogs on retinal spreading of depression.
van Harreveld A
J Neurobiol; 1979 Jul; 10(4):355-65. PubMed ID: 469526
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
Almquist RG; Chao WR; Jennings-White C
J Med Chem; 1985 Aug; 28(8):1067-71. PubMed ID: 2991518
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic preparation of 5-hydroxy-L-proline, N-Cbz-5-hydroxy-L-proline, and N-Boc-5-hydroxy-L-proline from (α-N-protected)-L-ornithine using a transaminase or an amine oxidase.
Hanson RL; Johnston RM; Goldberg SL; Parker WL; Patel RN
Enzyme Microb Technol; 2011 May; 48(6-7):445-53. PubMed ID: 22113015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
